These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 6812141

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus.
    Galzin AM, Moret C, Verzier B, Langer SZ.
    J Pharmacol Exp Ther; 1985 Oct; 235(1):200-11. PubMed ID: 2864432
    [Abstract] [Full Text] [Related]

  • 4. Alterations in responses to LSD in humans associated with chronic administration of tricyclic antidepressants, monoamine oxidase inhibitors or lithium.
    Bonson KR, Murphy DL.
    Behav Brain Res; 1996 Oct; 73(1-2):229-33. PubMed ID: 8788508
    [Abstract] [Full Text] [Related]

  • 5. Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain.
    Savage DD, Mendels J, Frazer A.
    J Pharmacol Exp Ther; 1980 Feb; 212(2):259-63. PubMed ID: 7351637
    [Abstract] [Full Text] [Related]

  • 6. Serotonin accumulation after monoamine oxidase inhibition. Effects of decreased impulse flow and of some anti-depressants and hallucinogens.
    Meek JL, Fuxe K.
    Biochem Pharmacol; 1971 Mar; 20(3):693-706. PubMed ID: 5150164
    [No Abstract] [Full Text] [Related]

  • 7. Serotonin-containing neurons in brain: depression of firing by monoamine oxidase inhibitors.
    Aghajanian GK, Graham AW, Sheard MH.
    Science; 1970 Sep 11; 169(3950):1100-2. PubMed ID: 5449322
    [Abstract] [Full Text] [Related]

  • 8. Effects of repeated administration of the monoamine oxidase inhibitor phenelzine on the discriminability of d-lysergic acid diethylamide (LSD) and 1-(m-trifluoromethylphenyl) piperazine (TFMPP).
    Cunningham KA, Carroll BA, Appel JB.
    Psychopharmacology (Berl); 1986 Sep 11; 89(1):134-5. PubMed ID: 3090587
    [Abstract] [Full Text] [Related]

  • 9. Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity.
    Lucki I, Ward HR, Frazer A.
    J Pharmacol Exp Ther; 1989 Apr 11; 249(1):155-64. PubMed ID: 2709329
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of nialamide and clomipramine on serotonin efflux and autoreceptors.
    Offord SJ, Warwick RO.
    Pharmacol Biochem Behav; 1987 Mar 11; 26(3):593-600. PubMed ID: 2437597
    [Abstract] [Full Text] [Related]

  • 11. Suppression of the hypo- and hyperthermic responses to 5-HT agonists following the repeated administration of monoamine oxidase inhibitors.
    Gudelsky GA, Koenig JI, Jackman H, Meltzer HY.
    Psychopharmacology (Berl); 1986 Mar 11; 90(3):403-7. PubMed ID: 2947256
    [Abstract] [Full Text] [Related]

  • 12. The effect of some tricyclic antidepressants on the inhibition of mouse brain monoamine oxidase in-vivo by phenelzine.
    Green AL, O'Grady JE, Vass M.
    J Pharm Pharmacol; 1989 Jan 11; 41(1):50-1. PubMed ID: 2565965
    [Abstract] [Full Text] [Related]

  • 13. Effect of acute axotomy (spinal cord transection) on the turnover of 5-hydroxytryptamine.
    Andén NE.
    Adv Biochem Psychopharmacol; 1974 Jan 11; 10():35-43. PubMed ID: 4276958
    [No Abstract] [Full Text] [Related]

  • 14. Interactions of a non-selective monoamine oxidase inhibitor, phenelzine, with inhibitors of 5-hydroxytryptamine, dopamine or noradrenaline re-uptake.
    Marley E, Wozniak KM.
    J Psychiatr Res; 1984 Jan 11; 18(2):173-89. PubMed ID: 6747915
    [Abstract] [Full Text] [Related]

  • 15. The serotonin receptor agonist 5-methoxy-N,N-dimethyltryptamine facilitates noradrenaline release from rat spinal cord slices and inhibits monoamine oxidase activity.
    Reimann W, Schneider F.
    Gen Pharmacol; 1993 Mar 11; 24(2):449-53. PubMed ID: 8482527
    [Abstract] [Full Text] [Related]

  • 16. Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling.
    Buchborn T, Schröder H, Höllt V, Grecksch G.
    J Psychopharmacol; 2014 Jun 11; 28(6):545-52. PubMed ID: 24785760
    [Abstract] [Full Text] [Related]

  • 17. [Activity of toloxatone, antidepressive agents and various other reserpine antagonists on three behavior tests, in the mouse treated with nialamide].
    Gouret C, Raynaud G.
    Therapie; 1975 Jun 11; 30(2):225-30. PubMed ID: 1080583
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Specificity of a rat behavioral model for serotonin receptor activation.
    Sloviter RS, Drust EG, Connor JD.
    J Pharmacol Exp Ther; 1978 Aug 11; 206(2):339-47. PubMed ID: 682117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.